PROVIDER PROFILE · NPI 1114952264

Peter Balingit

Internal MedicineSylmar, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$12K

Distinct drugs

Brand share

22.4%

Top prescribed drugs

Losartan Potassium16 claims

Atorvastatin Calcium11 claims

Metformin Hcl11 claims

Tirzepatide11 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Peter Balingit's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MHIRAMARC MANAGEMENT LLC	96	183
MIRAFAITH HOSPICE INC.	12	19

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
MHIRAMARC MANAGEMENT LLC	136	686
MACHOWSKY, HELMUT	136	686
MIRAFAITH HOSPICE INC.	22	75
Rodolfo Protacio Internal Medicine · Glendale, CA	15	53
COUNTY OF LOS ANGELES	14	26

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history